newsfilter
← Latest News
PR Newswire·

Shareholders who lost money in shares of The Chemours Company (NYSE: CC) should contact Wolf Haldenstein Immediately

CC
  • Wolf Haldenstein Adler Freeman & Herz LLP filed a securities class action lawsuit in the U.S. District Court for the District of Delaware against The Chemours Company (NYSE: CC).
  • The class period covers purchases of Chemours securities between February 20, 2026, and August 4, 2026.
  • The lead plaintiff deadline is set for December 7, 2026.
  • The complaint alleges defendants failed to disclose that aftermarket demand for Opteon products was overstated due to prior overselling.
  • Defendants are accused of providing unreliable financial guidance for the 2026 fiscal year and making materially false public statements.
  • On August 4, 2026, Chemours reduced its full-year adjusted EBITDA guidance to $775 million-$825 million from a previous range of $800 million-$900 million.
  • Management admitted during an earnings call that channel oversupply created an inventory buildup, with approximately $65 million in sales potentially misallocated to the current year.
  • Chemours stock fell $3.34 per share (18.63%) to close at $14.59 on August 5, 2026, following the announcement.
  • The firm states there is no cost or obligation for investors to contact them regarding potential participation in the case.